减肥药的救赎叙事：一场关于身体定价权的 scamThe Salvation Narrative of Weight-Loss Drugs: A Scam of Body Pricing Power
GLP-1 类药物的流行，本质上是一场认知入口的武器化。它向大众投放了一种极其危险的叙事：肥胖不再是复杂的生物与社会共谋的结果，而是一个可以通过‘打针’快速修复的 bug。当这种叙事被名人效应和商业 PR 放大到极致，它就成了一把双刃剑——对于响应者，它是捷径；对于像 Mercedes 这样不响应的人，它成了二次伤害的凶器。
最残酷的暴力不在于药物失效，而在于这种‘救赎叙事’如何重新定义了身体的失败。在‘只要打针就能瘦’的文化暴力下，不响应药物的人在潜意识中完成了自我客体化：她们不再认为自己是处于某种生物困境中的主体，而认为自己的身体是一个‘不工作’的、残次的产品。这种 shame（羞耻感）是典型的 structural violence，它将生物学的个体差异（genetic variants）转化为心理上的道德亏欠。
有趣的是，文中提到雌激素（oestrogen）会影响药效。这再次证明了生物墙的存在，但医药工业在推销产品时，习惯性地抹除这些复杂的生物事实，转而提供一个简化的、标准化的‘最优解’。这种简化是为了最大化利润，而非为了公正的表达。当一个人在尝试了所有昂贵药物却依然面对‘海洛因式戒断’的食欲时，她面对的不仅是生物性的抵抗，更是被资本主义定价权操纵后的绝望。
所谓的‘运气不好’（luck）是对受害者最轻佻的安慰。在这种商业 scam 中，真正的 luck 是你恰好符合药厂定义的‘标准人体’，从而在存在性战争中获得了一张进入‘美学特权阶层’的入场券。而那些被排除在外的人，则在巨大的账单和破碎的自尊中，承担了这场叙事实验的所有成本。
The craze over GLP-1 drugs is essentially a weaponisation of the cognitive entry point. It feeds the public a dangerous narrative: obesity is no longer a complex result of biological and social complicity, but a simple bug that can be 'patched' with a jab. When this narrative is amplified by celebrity endorsements and corporate PR, it becomes a double-edged sword—a shortcut for responders, and a weapon of secondary trauma for those like Mercedes.
The most brutal violence isn't the drug's failure, but how this 'salvation narrative' redefines bodily failure. Under the cultural violence of 'just take a shot to lose weight,' non-responders subconsciously complete a process of self-objectification. They no longer see themselves as subjects in a biological struggle, but as 'broken' or defective products. This shame is a textbook example of structural violence, converting biological individual differences (genetic variants) into a psychological moral debt.
It is telling that oestrogen affects the response. This again proves the existence of the Biological Wall, yet the pharmaceutical industry habitually erases these complexities to offer a simplified, standardised 'optimal expression.' This simplification serves profit maximisation, not Just Expressions. When a person faces 'heroin-like withdrawal' cravings despite every expensive drug, they are battling not just biological resistance, but the despair of being priced out by capitalist pricing power.
Calling it 'bad luck' is a flippant consolation. In this commercial scam, the only real 'luck' is fitting the 'standard body' defined by Big Pharma, thereby gaining a ticket into the aesthetic privileged class. Those excluded are left to bear the full cost of this narrative experiment, paid for in massive bills and shattered self-esteem.